The test was performed as previously described with some modifications (41). blood matched the kinetic of changes in behavior measured using the open field test. Treatment with glatiramer acetate, a well-known immunomodulatory drug for MS, suppressed behavioral changes while retaining the T cells in the draining lymph nodes. Together these results provide evidence of a positive correlation between the emigration of T cells in circulation and changes in emotions during chronic inflammatory diseases. The validation of these findings in the clinic might help to better understand the cause of the emotional and psychological burden of patients suffering MS or other autoimmune diseases. Most importantly our study suggests novel therapeutic venues for the treatment of the emotional changes associated with autoimmunity. Keywords:T cells, multiple sclerosis, immunomodulation, mood disorders, behavior == Introduction == A wealth of studies in the literature has indicated a significant increase in emotional changes in patients suffering from multiple sclerosis (MS) (13) as well as from other autoimmune diseases (4). Major depression (57), bipolar depression (2,8), anxiety (911), alcohol abuse (12,13), and other substance abuses (14) are all at an increased prevalence in MS population. These emotional dysfunctions are not simply a reactive psychological response to the impact of this pathology on the patients life style and have been correlated with the development of MS and other autoimmune diseases. Indeed, the depression and anxiety rates are higher in MS than in those patients experiencing other chronic diseases (15). It is in fact estimated that between 40 and 50% of patients with MS will experience a type of depression within their lifetime. As consequence of this, MS patients show a higher rate of suicides when compared to a normal population with most occurring within 5 years JNJ0966 of diagnosis (16,17). One of the most unexpected aspects of the correlation between emotional disorders and MS is their association in time. Recent evidence suggests that depression usually presents JNJ0966 before the onset of MS symptoms and even before analysis (9,18) and with over a third of MS individuals having a family history of major depression (19,20). Indeed, looking at MS patient sites1,2as well as at systematic epidemiological studies, it is obvious that individuals often lament of having suffered panic attack or panic over limited period of time. In other words, individuals suffered from unpredicted attacks of panic that did not necessarily correlated with any manifestation Rabbit Polyclonal to Tubulin beta of the disease. In other instances, it seems that these bouts of anxiety and panic assault precede or adhere to the same pattern of MS. Most intriguingly, MS and mental disorders like major depression display a large degree of similarities. Indeed, both can provoke cognitive impairment, muscle mass weakness, or tiredness (2123). Previous studies, summarized in Table1, tackled the behavioral modifications happening in mouse models of MS, the experimental autoimmune encephalomyelitis (EAE). These studies reported either no changes (24) or an inverse correlation between sociable exploration and the rise of inflammatory mediators including IL-1, TNF-, and PGE2(25). Conversely, Peruga et al. shown that mice immunized having a suboptimal dose of MOG3555(50 g) showed the manifestation of engine impairment at day time 60 after immunization and experienced an increase anxiety-like behavior that correlated with an increase in the level of TNF- and with neuronal loss in the hippocampus (26). This was also associated with a doubled depressive-like behavior in the learned helplessness paradigm. In a more recent study, Haji JNJ0966 et al. assessed the behavior of mice subjected to EAE before locomotor problems started to display (27). Their results suggested firstly that high panic indexes in EAE mice precede the appearance of motor problems and secondly that TNF- has a pivotal part in the high panic response because of the ability of this cytokine to cause striatum swelling and microglia activation. In addition, intracerebroventricular administration of etanercept, an.